Browse by Publication
Up a level |
Number of items: 5.
2019
Weston, Philip SJ;
Poole, Teresa;
O'Connor, Antoinette;
Heslegrave, Amanda;
Ryan, Natalie S;
Liang, Yuying;
Druyeh, Ronald;
Mead, Simon;
Blennow, Kaj;
Schott, Jonathan M;
+3 more...
Frost, Chris;
Zetterberg, Henrik;
Fox, Nick C;
(2019)
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.
Alzheimer's research & therapy, 11 (1).
19-.
ISSN 1758-9193
DOI: https://doi.org/10.1186/s13195-019-0472-5
2018
Hardy, CJD;
Marshall, CR;
Bond, RL;
Russell, LL;
Dick, K;
Ariti, C;
Thomas, DL;
Ross, SJ;
Agustus, JL;
Crutch, SJ;
+3 more...
Rohrer, JD;
Bamiou, DE;
Warren, JD;
(2018)
Retained capacity for perceptual learning of degraded speech in primary progressive aphasia and Alzheimer's disease.
Alzheimer's research & therapy, 10 (1).
p. 70.
ISSN 1758-9193
DOI: https://doi.org/10.1186/s13195-018-0399-2
Paterson, RW;
Slattery, CF;
Poole, T;
Nicholas, JM;
Magdalinou, NK;
Toombs, J;
Chapman, MD;
Lunn, MP;
Heslegrave, AJ;
Foiani, MS;
+10 more...
Weston, PSJ;
Keshavan, A;
Rohrer, JD;
Rossor, MN;
Warren, JD;
Mummery, CJ;
Blennow, K;
Fox, NC;
Zetterberg, H;
Schott, JM;
(2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Alzheimer's research & therapy, 10 (1).
p. 32.
ISSN 1758-9193
DOI: https://doi.org/10.1186/s13195-018-0361-3
Ridha, BH;
Crutch, S;
Cutler, D;
Frost, C;
Knight, W;
Barker, S;
Epie, N;
Warrington, EK;
Kukkastenvehmas, R;
Douglas, J;
+1 more...
Rossor, MN;
(2018)
A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.
Alzheimer's research & therapy, 10 (1).
p. 44.
ISSN 1758-9193
DOI: https://doi.org/10.1186/s13195-018-0363-1
Woollacott, IOC;
Nicholas, JM;
Heslegrave, A;
Heller, C;
Foiani, MS;
Dick, KM;
Russell, LL;
Paterson, RW;
Keshavan, A;
Fox, NC;
+4 more...
Warren, JD;
Schott, JM;
Zetterberg, H;
Rohrer, JD;
(2018)
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Alzheimer's research & therapy, 10 (1).
p. 79.
ISSN 1758-9193
DOI: https://doi.org/10.1186/s13195-018-0405-8